|
市場調査レポート
商品コード
1632986
免疫療法薬市場：市場分析と2033年までの予測 - タイプ別、製品別、用途別、技術別、エンドユーザー別、プロセス別、モード別、段階別Immunotherapy Drugs Market Analysis and Forecast to 2033: Type, Product, Application, Technology, End User, Process, Mode, Stage |
||||||
|
|||||||
価格
| 免疫療法薬市場：市場分析と2033年までの予測 - タイプ別、製品別、用途別、技術別、エンドユーザー別、プロセス別、モード別、段階別 |
|
出版日: 2025年01月13日
発行: Global Insight Services
ページ情報: 英文 361 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
概要
免疫療法薬市場は、2023年の1,630億米ドルから2033年には3,750億米ドルに拡大し、CAGRは8.5%になると推定されます。
免疫療法薬市場は、がんや自己免疫疾患をはじめとする疾病と闘うために、身体の免疫システムを利用・強化する治療薬の開発・商業化を専門とする業界を包括しています。この市場には、モノクローナル抗体、チェックポイント阻害剤、ワクチン、細胞療法などが含まれ、個別化医療へのパラダイムシフトを表すとともに、患者の予後改善と革新的な治療法への有望な道を提供しています。
同市場は、主にがん治療と自己免疫疾患管理の進歩に牽引されて成長を遂げています。モノクローナル抗体は、その標的作用と様々ながんの治療における有効性により、市場をリードしています。チェックポイント阻害剤は、腫瘍に対する身体の免疫反応を解き放つ能力によって牽引力を得ており、2番目に高い業績を上げているサブセグメントです。北米地域は、強力なヘルスケアインフラと大規模な研究開発投資に支えられて市場を独占しています。欧州は、有利な政府政策と新規治療法の採用増加に支えられて、僅差で続いています。これらの地域の中では、米国とドイツが、イノベーションへの取り組みと先進的なヘルスケアソリューションへのアクセスを反映し、トップクラスの実績を上げています。アジア太平洋地域は、特に中国とインドにおける医療費の増加と患者数の増加に牽引され、有望な市場として浮上しています。これらの洞察は、免疫療法薬市場のダイナミックな性質と有望な機会を裏付けています。
2023年、免疫療法薬市場は堅調な伸びを示し、市場規模は3億2,000万ユニットに達しました。モノクローナル抗体分野が45％で最大の市場シェアを占め、次いで免疫チェックポイント阻害薬が30％、がんワクチンが25％となっています。この分布は、標的療法の採用が増加していることと、世界のがん罹患率の上昇を反映しています。モノクローナル抗体分野は、バイオテクノロジーと個別化医療の進歩が特に市場を牽引しています。
競合情勢は、Roche、Merck & Co.、Bristol-Myers Squibbなどの主要企業が支配的であり、それぞれが戦略的パートナーシップと革新的な研究開発を活用して市場での地位を高めています。FDA承認や特許法などの規制の影響は、市場力学に大きな影響を与えます。新興国市場のビジネスチャンスや新規免疫治療薬の開発により、市場は拡大基調にあります。しかし、治療費の高騰や規制要件の厳格化といった課題は依然として残っています。薬剤開発における人工知能の統合は、成長をさらに促進すると予想されます。
北米は、主に米国が牽引して免疫療法薬市場を独占しています。同地域は、強固なヘルスケアインフラと研究開発への多額の投資というメリットを享受しています。主要製薬企業が存在し、技術革新に力を入れていることが市場をさらに強化しています。同地域では慢性疾患の罹患率が高いことも、高度な治療オプションへの需要を後押ししています。
欧州は免疫療法薬市場で大きなシェアを占めており、ドイツ、フランス、英国が主要な貢献国です。同地域の確立されたヘルスケアシステムと強力な規制の枠組みが市場の成長を支えています。欧州諸国は個別化医療への投資も進めており、免疫療法薬の採用を後押ししています。がん研究や治療法の革新に重点が置かれていることも、この地域の原動力となっています。
アジア太平洋地域は免疫療法薬市場で急成長を遂げています。医療費の増加と先進治療に対する意識の高まりが、この市場拡大に寄与しています。中国やインドのような国々は、ヘルスケアのインフラや研究イニシアティブに投資しています。これらの国々では、がんやその他の慢性疾患の有病率が高まっており、効果的な免疫療法治療に対する需要が高まっています。
免疫療法薬市場では、ラテンアメリカや中東・アフリカ地域が徐々に台頭してきています。現在、これらの地域の市場シェアは小さいですが、ヘルスケア投資の増加や先進医療へのアクセスの向上が成長の原動力になると期待されています。これらの地域の政府は、市場開拓を支援するため、ヘルスケア施設の充実と研究開発に注力しています。
目次
第1章 免疫療法薬の市場概要
- 調査目的
- 免疫療法薬市場の定義と調査範囲
- レポートの制限事項
- 調査対象年および通貨
- 調査手法
第2章 エグゼクティブサマリー
第3章 市場に関する重要考察
第4章 免疫療法薬市場の展望
- 免疫療法薬市場のセグメンテーション
- 市場力学
- ポーターのファイブフォース分析
- PESTLE分析
- バリューチェーン分析
- 4Pモデル
- ANSOFFマトリックス
第5章 免疫療法薬の市場戦略
- 親市場分析
- 需給分析
- 消費者の購買意欲
- ケーススタディ分析
- 価格分析
- 規制状況
- サプライチェーン分析
- 競合製品分析
- 最近の動向
第6章 免疫療法薬の市場規模
- 免疫療法薬の市場規模：金額別
- 免疫療法薬の市場規模：数量別
第7章 免疫療法薬市場：タイプ別
- 市場概要
- モノクローナル抗体
- チェックポイント阻害剤
- サイトカイン
- がんワクチン
- 養子細胞療法
- がん溶解性ウイルス療法
- その他
第8章 免疫療法薬市場：製品別
- 市場概要
- 治療用ワクチン
- 免疫チェックポイント阻害薬
- 非特異的免疫療法薬
- がん細胞ウイルス免疫療法
- CAR-T細胞療法
- その他
第9章 免疫療法薬市場：用途別
- 市場概要
- がん
- 自己免疫疾患
- 感染症
- 炎症性疾患
- その他
第10章 免疫療法薬市場：技術別
- 市場概要
- 遺伝子編集
- CRISPR
- RNA干渉
- ナノテクノロジー
- 組み換えDNA技術
- その他
第11章 免疫療法薬市場：エンドユーザー別
- 市場概要
- 病院
- 診療所
- 研究機関
- バイオ製薬会社
- その他
第12章 免疫療法薬市場：プロセス別
- 市場概要
- 製造
- 研究開発
- 臨床試験
- 薬事承認
- 上市
- その他
第13章 免疫療法薬市場：モード別
- 市場概要
- 静脈注射
- 経口
- 局所
- 吸入
- その他
第14章 免疫療法薬市場：段階別
- 市場概要
- 創薬
- 前臨床
- 臨床試験
- 承認
- 上市
- 市販後調査
- その他
第15章 免疫療法薬市場：地域別
- 概要
- 北米
- 米国
- カナダ
- 欧州
- 英国
- ドイツ
- フランス
- スペイン
- イタリア
- オランダ
- スウェーデン
- スイス
- デンマーク
- フィンランド
- ロシア
- その他欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- オーストラリア
- シンガポール
- インドネシア
- 台湾
- マレーシア
- その他アジア太平洋地域
- ラテンアメリカ
- ブラジル
- メキシコ
- アルゼンチン
- その他ラテンアメリカ
- 中東・アフリカ
- サウジアラビア
- アラブ首長国連邦
- 南アフリカ
- その他中東・アフリカ
第16章 競合情勢
- 概要
- 市場シェア分析
- 主要企業のポジショニング
- 競合リーダーシップマッピング
- ベンダーベンチマーキング
- 開発戦略のベンチマーキング
第17章 企業プロファイル
- Incyte
- BeiGene
- MacroGenics
- Adaptimmune Therapeutics
- Immunomedics
- Kite Pharma
- Juno Therapeutics
- Immunocore
- Bluebird Bio
- Celldex Therapeutics
- OncoMed Pharmaceuticals
- Argenx
- Cellectis
- Fate Therapeutics
- Gritstone Oncology
- Adaptimmune
- Allogene Therapeutics
- Iovance Biotherapeutics
- Zymeworks
- Compugen
目次
Product Code: GIS24892
The immunotherapy drugs market is estimated to expand from $163 billion in 2023 to $375 billion by 2033, with a compound annual growth rate (CAGR) of 8.5%.
The Immunotherapy Drugs Market encompasses the industry dedicated to developing and commercializing therapeutic agents that harness and enhance the body's immune system to combat diseases, notably cancer and autoimmune disorders. This market includes monoclonal antibodies, checkpoint inhibitors, vaccines, and cell therapies, representing a paradigm shift towards personalized medicine and offering promising avenues for improved patient outcomes and innovative treatment modalities.
The market is witnessing growth, primarily driven by advancements in cancer treatment and autoimmune disease management. Monoclonal antibodies lead the market, owing to their targeted action and efficacy in treating various cancers. Checkpoint inhibitors are the second highest performing sub-segment, gaining traction due to their ability to unleash the body's immune response against tumors. The North American region dominates the market, supported by strong healthcare infrastructure and significant R&D investments. Europe follows closely, bolstered by favorable government policies and increased adoption of novel therapies. Within these regions, the United States and Germany are the top-performing countries, reflecting their commitment to innovation and access to advanced healthcare solutions. The Asia-Pacific region is emerging as a lucrative market, driven by increasing healthcare expenditure and a growing patient population, particularly in China and India. These insights underscore the dynamic nature of the immunotherapy drugs market and the promising opportunities it presents.
In 2023, the Immunotherapy Drugs Market demonstrated robust growth, with the market volume reaching 320 million units. The monoclonal antibodies segment holds the largest market share at 45%, followed by immune checkpoint inhibitors at 30%, and cancer vaccines at 25%. This distribution reflects the increasing adoption of targeted therapies and the rising incidence of cancer worldwide. The monoclonal antibodies segment is particularly driven by advancements in biotechnology and personalized medicine.
The competitive landscape is dominated by key players such as Roche, Merck & Co., and Bristol-Myers Squibb, each leveraging strategic partnerships and innovative R&D to enhance their market positions. Regulatory influences, including FDA approvals and patent laws, significantly impact market dynamics. The market is poised for expansion, with opportunities in emerging markets and the development of novel immunotherapeutic agents. However, challenges such as high treatment costs and stringent regulatory requirements persist. The integration of artificial intelligence in drug development is expected to further propel growth.
North America dominates the immunotherapy drugs market, primarily driven by the United States. The region benefits from a robust healthcare infrastructure and significant investment in research and development. The presence of leading pharmaceutical companies and a strong focus on innovation further bolster this market. The high prevalence of chronic diseases in the region also fuels demand for advanced treatment options.
Europe holds a substantial share in the immunotherapy drugs market, with Germany, France, and the United Kingdom being key contributors. The region's well-established healthcare system and strong regulatory framework support market growth. European countries are also investing in personalized medicine, which enhances the adoption of immunotherapy drugs. The emphasis on cancer research and treatment innovation is a driving force in this region.
Asia Pacific is experiencing rapid growth in the immunotherapy drugs market. Rising healthcare expenditures and increasing awareness about advanced treatments contribute to this expansion. Countries like China and India are investing in healthcare infrastructure and research initiatives. The growing prevalence of cancer and other chronic diseases in these countries increases the demand for effective immunotherapy treatments.
Latin America and the Middle East & Africa regions are gradually emerging in the immunotherapy drugs market. Although these regions currently hold a smaller market share, increasing healthcare investments and improving access to advanced medical treatments are expected to drive growth. Governments in these regions are focusing on enhancing healthcare facilities and promoting research to support market development.
Key Companies
Incyte, Bei Gene, Macro Genics, Adaptimmune Therapeutics, Immunomedics, Kite Pharma, Juno Therapeutics, Immunocore, Bluebird Bio, Celldex Therapeutics, Onco Med Pharmaceuticals, Argenx, Cellectis, Fate Therapeutics, Gritstone Oncology, Adaptimmune, Allogene Therapeutics, Iovance Biotherapeutics, Zymeworks, Compugen
Sources
World Health Organization (WHO), U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institutes of Health (NIH), American Association for Cancer Research (AACR), International Agency for Research on Cancer (IARC), Centers for Disease Control and Prevention (CDC), World Cancer Research Fund International, International Society for Biological Therapy of Cancer (iSBTc), Cancer Research UK, National Cancer Institute (NCI), European Society for Medical Oncology (ESMO), Society for Immunotherapy of Cancer (SITC), National Comprehensive Cancer Network (NCCN), American Society of Clinical Oncology (ASCO), Australian Therapeutic Goods Administration (TGA), Canadian Agency for Drugs and Technologies in Health (CADTH), International Conference on Cancer Immunotherapy, International Immunocompromised Host Society (ICHS), International Cancer Immunotherapy Conference (CICON).
Research Scope
- Estimates and forecasts the overall market size across type, application, and region.
- Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
- Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
- Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
- Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
- Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
- Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.
Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.
TABLE OF CONTENTS
1: Immunotherapy Drugs Market Overview
- 1.1 Objectives of the Study
- 1.2 Immunotherapy Drugs Market Definition and Scope of the Report
- 1.3 Report Limitations
- 1.4 Years & Currency Considered in the Study
- 1.5 Research Methodologies
- 1.5.1 Secondary Research
- 1.5.2 Primary Research
- 1.5.3 Market Size Estimation: Top-Down Approach
- 1.5.4 Market Size Estimation: Bottom-Up Approach
- 1.5.5 Data Triangulation and Validation
2: Executive Summary
- 2.1 Summary
- 2.2 Key Opinion Leaders
- 2.3 Key Highlights of the Market, by Type
- 2.4 Key Highlights of the Market, by Product
- 2.5 Key Highlights of the Market, by Application
- 2.6 Key Highlights of the Market, by Technology
- 2.7 Key Highlights of the Market, by End User
- 2.8 Key Highlights of the Market, by Process
- 2.9 Key Highlights of the Market, by Mode
- 2.10 Key Highlights of the Market, by Stage
- 2.11 Key Highlights of the Market, by North America
- 2.12 Key Highlights of the Market, by Europe
- 2.13 Key Highlights of the Market, by Asia-Pacific
- 2.14 Key Highlights of the Market, by Latin America
- 2.15 Key Highlights of the Market, by Middle East
- 2.16 Key Highlights of the Market, by Africa
3: Premium Insights on the Market
- 3.1 Market Attractiveness Analysis, by Region
- 3.2 Market Attractiveness Analysis, by Type
- 3.3 Market Attractiveness Analysis, by Product
- 3.4 Market Attractiveness Analysis, by Application
- 3.5 Market Attractiveness Analysis, by Technology
- 3.6 Market Attractiveness Analysis, by End User
- 3.7 Market Attractiveness Analysis, by Process
- 3.8 Market Attractiveness Analysis, by Mode
- 3.9 Market Attractiveness Analysis, by Stage
- 3.10 Market Attractiveness Analysis, by North America
- 3.11 Market Attractiveness Analysis, by Europe
- 3.12 Market Attractiveness Analysis, by Asia-Pacific
- 3.13 Market Attractiveness Analysis, by Latin America
- 3.14 Market Attractiveness Analysis, by Middle East
- 3.15 Market Attractiveness Analysis, by Africa
4: Immunotherapy Drugs Market Outlook
- 4.1 Immunotherapy Drugs Market Segmentation
- 4.2 Market Dynamics
- 4.2.1 Market Drivers
- 4.2.2 Market Trends
- 4.2.3 Market Restraints
- 4.2.4 Market Opportunities
- 4.3 Porters Five Forces Analysis
- 4.3.1 Threat of New Entrants
- 4.3.2 Threat of Substitutes
- 4.3.3 Bargaining Power of Buyers
- 4.3.4 Bargaining Power of Supplier
- 4.3.5 Competitive Rivalry
- 4.4 PESTLE Analysis
- 4.5 Value Chain Analysis
- 4.6 4Ps Model
- 4.7 ANSOFF Matrix
5: Immunotherapy Drugs Immunotherapy Drugs Market Strategy
- 5.1 Parent Market Analysis
- 5.2 Supply-Demand Analysis
- 5.3 Consumer Buying Interest
- 5.4 Case Study Analysis
- 5.5 Pricing Analysis
- 5.6 Regulatory Landscape
- 5.7 Supply Chain Analysis
- 5.8 Competition Product Analysis
- 5.9 Recent Developments
6: Immunotherapy Drugs Market Size
- 6.1 Immunotherapy Drugs Market Size, by Value
- 6.2 Immunotherapy Drugs Market Size, by Volume
7: Immunotherapy Drugs Market, by Type
- 7.1 Market Overview
- 7.2 Monoclonal Antibodies
- 7.2.1 Key Market Trends & Opportunity Analysis
- 7.2.2 Market Size and Forecast, by Region
- 7.3 Checkpoint Inhibitors
- 7.3.1 Key Market Trends & Opportunity Analysis
- 7.3.2 Market Size and Forecast, by Region
- 7.4 Cytokines
- 7.4.1 Key Market Trends & Opportunity Analysis
- 7.4.2 Market Size and Forecast, by Region
- 7.5 Cancer Vaccines
- 7.5.1 Key Market Trends & Opportunity Analysis
- 7.5.2 Market Size and Forecast, by Region
- 7.6 Adoptive Cell Therapy
- 7.6.1 Key Market Trends & Opportunity Analysis
- 7.6.2 Market Size and Forecast, by Region
- 7.7 Oncolytic Virus Therapy
- 7.7.1 Key Market Trends & Opportunity Analysis
- 7.7.2 Market Size and Forecast, by Region
- 7.8 Others
- 7.8.1 Key Market Trends & Opportunity Analysis
- 7.8.2 Market Size and Forecast, by Region
8: Immunotherapy Drugs Market, by Product
- 8.1 Market Overview
- 8.2 Therapeutic Vaccines
- 8.2.1 Key Market Trends & Opportunity Analysis
- 8.2.2 Market Size and Forecast, by Region
- 8.3 Immune Checkpoint Inhibitors
- 8.3.1 Key Market Trends & Opportunity Analysis
- 8.3.2 Market Size and Forecast, by Region
- 8.4 Non-specific Immunotherapies
- 8.4.1 Key Market Trends & Opportunity Analysis
- 8.4.2 Market Size and Forecast, by Region
- 8.5 Oncolytic Virus Immunotherapy
- 8.5.1 Key Market Trends & Opportunity Analysis
- 8.5.2 Market Size and Forecast, by Region
- 8.6 CAR-T Cell Therapy
- 8.6.1 Key Market Trends & Opportunity Analysis
- 8.6.2 Market Size and Forecast, by Region
- 8.7 Others
- 8.7.1 Key Market Trends & Opportunity Analysis
- 8.7.2 Market Size and Forecast, by Region
9: Immunotherapy Drugs Market, by Application
- 9.1 Market Overview
- 9.2 Cancer
- 9.2.1 Key Market Trends & Opportunity Analysis
- 9.2.2 Market Size and Forecast, by Region
- 9.3 Autoimmune Diseases
- 9.3.1 Key Market Trends & Opportunity Analysis
- 9.3.2 Market Size and Forecast, by Region
- 9.4 Infectious Diseases
- 9.4.1 Key Market Trends & Opportunity Analysis
- 9.4.2 Market Size and Forecast, by Region
- 9.5 Inflammatory Diseases
- 9.5.1 Key Market Trends & Opportunity Analysis
- 9.5.2 Market Size and Forecast, by Region
- 9.6 Others
- 9.6.1 Key Market Trends & Opportunity Analysis
- 9.6.2 Market Size and Forecast, by Region
10: Immunotherapy Drugs Market, by Technology
- 10.1 Market Overview
- 10.2 Gene Editing
- 10.2.1 Key Market Trends & Opportunity Analysis
- 10.2.2 Market Size and Forecast, by Region
- 10.3 CRISPR
- 10.3.1 Key Market Trends & Opportunity Analysis
- 10.3.2 Market Size and Forecast, by Region
- 10.4 RNA Interference
- 10.4.1 Key Market Trends & Opportunity Analysis
- 10.4.2 Market Size and Forecast, by Region
- 10.5 Nanotechnology
- 10.5.1 Key Market Trends & Opportunity Analysis
- 10.5.2 Market Size and Forecast, by Region
- 10.6 Recombinant DNA Technology
- 10.6.1 Key Market Trends & Opportunity Analysis
- 10.6.2 Market Size and Forecast, by Region
- 10.7 Others
- 10.7.1 Key Market Trends & Opportunity Analysis
- 10.7.2 Market Size and Forecast, by Region
11: Immunotherapy Drugs Market, by End User
- 11.1 Market Overview
- 11.2 Hospitals
- 11.2.1 Key Market Trends & Opportunity Analysis
- 11.2.2 Market Size and Forecast, by Region
- 11.3 Clinics
- 11.3.1 Key Market Trends & Opportunity Analysis
- 11.3.2 Market Size and Forecast, by Region
- 11.4 Research Institutes
- 11.4.1 Key Market Trends & Opportunity Analysis
- 11.4.2 Market Size and Forecast, by Region
- 11.5 Biopharmaceutical Companies
- 11.5.1 Key Market Trends & Opportunity Analysis
- 11.5.2 Market Size and Forecast, by Region
- 11.6 Others
- 11.6.1 Key Market Trends & Opportunity Analysis
- 11.6.2 Market Size and Forecast, by Region
12: Immunotherapy Drugs Market, by Process
- 12.1 Market Overview
- 12.2 Manufacturing
- 12.2.1 Key Market Trends & Opportunity Analysis
- 12.2.2 Market Size and Forecast, by Region
- 12.3 Research and Development
- 12.3.1 Key Market Trends & Opportunity Analysis
- 12.3.2 Market Size and Forecast, by Region
- 12.4 Clinical Trials
- 12.4.1 Key Market Trends & Opportunity Analysis
- 12.4.2 Market Size and Forecast, by Region
- 12.5 Regulatory Approval
- 12.5.1 Key Market Trends & Opportunity Analysis
- 12.5.2 Market Size and Forecast, by Region
- 12.6 Commercialization
- 12.6.1 Key Market Trends & Opportunity Analysis
- 12.6.2 Market Size and Forecast, by Region
- 12.7 Others
- 12.7.1 Key Market Trends & Opportunity Analysis
- 12.7.2 Market Size and Forecast, by Region
13: Immunotherapy Drugs Market, by Mode
- 13.1 Market Overview
- 13.2 Intravenous
- 13.2.1 Key Market Trends & Opportunity Analysis
- 13.2.2 Market Size and Forecast, by Region
- 13.3 Oral
- 13.3.1 Key Market Trends & Opportunity Analysis
- 13.3.2 Market Size and Forecast, by Region
- 13.4 Topical
- 13.4.1 Key Market Trends & Opportunity Analysis
- 13.4.2 Market Size and Forecast, by Region
- 13.5 Inhalation
- 13.5.1 Key Market Trends & Opportunity Analysis
- 13.5.2 Market Size and Forecast, by Region
- 13.6 Others
- 13.6.1 Key Market Trends & Opportunity Analysis
- 13.6.2 Market Size and Forecast, by Region
14: Immunotherapy Drugs Market, by Stage
- 14.1 Market Overview
- 14.2 Discovery
- 14.2.1 Key Market Trends & Opportunity Analysis
- 14.2.2 Market Size and Forecast, by Region
- 14.3 Preclinical
- 14.3.1 Key Market Trends & Opportunity Analysis
- 14.3.2 Market Size and Forecast, by Region
- 14.4 Clinical
- 14.4.1 Key Market Trends & Opportunity Analysis
- 14.4.2 Market Size and Forecast, by Region
- 14.5 Approval
- 14.5.1 Key Market Trends & Opportunity Analysis
- 14.5.2 Market Size and Forecast, by Region
- 14.6 Launch
- 14.6.1 Key Market Trends & Opportunity Analysis
- 14.6.2 Market Size and Forecast, by Region
- 14.7 Post-market Surveillance
- 14.7.1 Key Market Trends & Opportunity Analysis
- 14.7.2 Market Size and Forecast, by Region
- 14.8 Others
- 14.8.1 Key Market Trends & Opportunity Analysis
- 14.8.2 Market Size and Forecast, by Region
15: Immunotherapy Drugs Market, by Region
- 15.1 Overview
- 15.2 North America
- 15.2.1 Key Market Trends and Opportunities
- 15.2.2 North America Market Size and Forecast, by Type
- 15.2.3 North America Market Size and Forecast, by Product
- 15.2.4 North America Market Size and Forecast, by Application
- 15.2.5 North America Market Size and Forecast, by Technology
- 15.2.6 North America Market Size and Forecast, by End User
- 15.2.7 North America Market Size and Forecast, by Process
- 15.2.8 North America Market Size and Forecast, by Mode
- 15.2.9 North America Market Size and Forecast, by Stage
- 15.2.10 North America Market Size and Forecast, by Country
- 15.2.11 United States
- 15.2.9.1 United States Market Size and Forecast, by Type
- 15.2.9.2 United States Market Size and Forecast, by Product
- 15.2.9.3 United States Market Size and Forecast, by Application
- 15.2.9.4 United States Market Size and Forecast, by Technology
- 15.2.9.5 United States Market Size and Forecast, by End User
- 15.2.9.6 United States Market Size and Forecast, by Process
- 15.2.9.7 United States Market Size and Forecast, by Mode
- 15.2.9.8 United States Market Size and Forecast, by Stage
- 15.2.9.9 Local Competition Analysis
- 15.2.9.10 Local Market Analysis
- 15.2.1 Canada
- 15.2.10.1 Canada Market Size and Forecast, by Type
- 15.2.10.2 Canada Market Size and Forecast, by Product
- 15.2.10.3 Canada Market Size and Forecast, by Application
- 15.2.10.4 Canada Market Size and Forecast, by Technology
- 15.2.10.5 Canada Market Size and Forecast, by End User
- 15.2.10.6 Canada Market Size and Forecast, by Process
- 15.2.10.7 Canada Market Size and Forecast, by Mode
- 15.2.10.8 Canada Market Size and Forecast, by Stage
- 15.2.10.9 Local Competition Analysis
- 15.2.10.10 Local Market Analysis
- 15.1 Europe
- 15.3.1 Key Market Trends and Opportunities
- 15.3.2 Europe Market Size and Forecast, by Type
- 15.3.3 Europe Market Size and Forecast, by Product
- 15.3.4 Europe Market Size and Forecast, by Application
- 15.3.5 Europe Market Size and Forecast, by Technology
- 15.3.6 Europe Market Size and Forecast, by End User
- 15.3.7 Europe Market Size and Forecast, by Process
- 15.3.8 Europe Market Size and Forecast, by Mode
- 15.3.9 Europe Market Size and Forecast, by Stage
- 15.3.10 Europe Market Size and Forecast, by Country
- 15.3.11 United Kingdom
- 15.3.9.1 United Kingdom Market Size and Forecast, by Type
- 15.3.9.2 United Kingdom Market Size and Forecast, by Product
- 15.3.9.3 United Kingdom Market Size and Forecast, by Application
- 15.3.9.4 United Kingdom Market Size and Forecast, by Technology
- 15.3.9.5 United Kingdom Market Size and Forecast, by End User
- 15.3.9.6 United Kingdom Market Size and Forecast, by Process
- 15.3.9.7 United Kingdom Market Size and Forecast, by Mode
- 15.3.9.8 United Kingdom Market Size and Forecast, by Stage
- 15.3.9.9 Local Competition Analysis
- 15.3.9.10 Local Market Analysis
- 15.3.1 Germany
- 15.3.10.1 Germany Market Size and Forecast, by Type
- 15.3.10.2 Germany Market Size and Forecast, by Product
- 15.3.10.3 Germany Market Size and Forecast, by Application
- 15.3.10.4 Germany Market Size and Forecast, by Technology
- 15.3.10.5 Germany Market Size and Forecast, by End User
- 15.3.10.6 Germany Market Size and Forecast, by Process
- 15.3.10.7 Germany Market Size and Forecast, by Mode
- 15.3.10.8 Germany Market Size and Forecast, by Stage
- 15.3.10.9 Local Competition Analysis
- 15.3.10.10 Local Market Analysis
- 15.3.1 France
- 15.3.11.1 France Market Size and Forecast, by Type
- 15.3.11.2 France Market Size and Forecast, by Product
- 15.3.11.3 France Market Size and Forecast, by Application
- 15.3.11.4 France Market Size and Forecast, by Technology
- 15.3.11.5 France Market Size and Forecast, by End User
- 15.3.11.6 France Market Size and Forecast, by Process
- 15.3.11.7 France Market Size and Forecast, by Mode
- 15.3.11.8 France Market Size and Forecast, by Stage
- 15.3.11.9 Local Competition Analysis
- 15.3.11.10 Local Market Analysis
- 15.3.1 Spain
- 15.3.12.1 Spain Market Size and Forecast, by Type
- 15.3.12.2 Spain Market Size and Forecast, by Product
- 15.3.12.3 Spain Market Size and Forecast, by Application
- 15.3.12.4 Spain Market Size and Forecast, by Technology
- 15.3.12.5 Spain Market Size and Forecast, by End User
- 15.3.12.6 Spain Market Size and Forecast, by Process
- 15.3.12.7 Spain Market Size and Forecast, by Mode
- 15.3.12.8 Spain Market Size and Forecast, by Stage
- 15.3.12.9 Local Competition Analysis
- 15.3.12.10 Local Market Analysis
- 15.3.1 Italy
- 15.3.13.1 Italy Market Size and Forecast, by Type
- 15.3.13.2 Italy Market Size and Forecast, by Product
- 15.3.13.3 Italy Market Size and Forecast, by Application
- 15.3.13.4 Italy Market Size and Forecast, by Technology
- 15.3.13.5 Italy Market Size and Forecast, by End User
- 15.3.13.6 Italy Market Size and Forecast, by Process
- 15.3.13.7 Italy Market Size and Forecast, by Mode
- 15.3.13.8 Italy Market Size and Forecast, by Stage
- 15.3.13.9 Local Competition Analysis
- 15.3.13.10 Local Market Analysis
- 15.3.1 Netherlands
- 15.3.14.1 Netherlands Market Size and Forecast, by Type
- 15.3.14.2 Netherlands Market Size and Forecast, by Product
- 15.3.14.3 Netherlands Market Size and Forecast, by Application
- 15.3.14.4 Netherlands Market Size and Forecast, by Technology
- 15.3.14.5 Netherlands Market Size and Forecast, by End User
- 15.3.14.6 Netherlands Market Size and Forecast, by Process
- 15.3.14.7 Netherlands Market Size and Forecast, by Mode
- 15.3.14.8 Netherlands Market Size and Forecast, by Stage
- 15.3.14.9 Local Competition Analysis
- 15.3.14.10 Local Market Analysis
- 15.3.1 Sweden
- 15.3.15.1 Sweden Market Size and Forecast, by Type
- 15.3.15.2 Sweden Market Size and Forecast, by Product
- 15.3.15.3 Sweden Market Size and Forecast, by Application
- 15.3.15.4 Sweden Market Size and Forecast, by Technology
- 15.3.15.5 Sweden Market Size and Forecast, by End User
- 15.3.15.6 Sweden Market Size and Forecast, by Process
- 15.3.15.7 Sweden Market Size and Forecast, by Mode
- 15.3.15.8 Sweden Market Size and Forecast, by Stage
- 15.3.15.9 Local Competition Analysis
- 15.3.15.10 Local Market Analysis
- 15.3.1 Switzerland
- 15.3.16.1 Switzerland Market Size and Forecast, by Type
- 15.3.16.2 Switzerland Market Size and Forecast, by Product
- 15.3.16.3 Switzerland Market Size and Forecast, by Application
- 15.3.16.4 Switzerland Market Size and Forecast, by Technology
- 15.3.16.5 Switzerland Market Size and Forecast, by End User
- 15.3.16.6 Switzerland Market Size and Forecast, by Process
- 15.3.16.7 Switzerland Market Size and Forecast, by Mode
- 15.3.16.8 Switzerland Market Size and Forecast, by Stage
- 15.3.16.9 Local Competition Analysis
- 15.3.16.10 Local Market Analysis
- 15.3.1 Denmark
- 15.3.17.1 Denmark Market Size and Forecast, by Type
- 15.3.17.2 Denmark Market Size and Forecast, by Product
- 15.3.17.3 Denmark Market Size and Forecast, by Application
- 15.3.17.4 Denmark Market Size and Forecast, by Technology
- 15.3.17.5 Denmark Market Size and Forecast, by End User
- 15.3.17.6 Denmark Market Size and Forecast, by Process
- 15.3.17.7 Denmark Market Size and Forecast, by Mode
- 15.3.17.8 Denmark Market Size and Forecast, by Stage
- 15.3.17.9 Local Competition Analysis
- 15.3.17.10 Local Market Analysis
- 15.3.1 Finland
- 15.3.18.1 Finland Market Size and Forecast, by Type
- 15.3.18.2 Finland Market Size and Forecast, by Product
- 15.3.18.3 Finland Market Size and Forecast, by Application
- 15.3.18.4 Finland Market Size and Forecast, by Technology
- 15.3.18.5 Finland Market Size and Forecast, by End User
- 15.3.18.6 Finland Market Size and Forecast, by Process
- 15.3.18.7 Finland Market Size and Forecast, by Mode
- 15.3.18.8 Finland Market Size and Forecast, by Stage
- 15.3.18.9 Local Competition Analysis
- 15.3.18.10 Local Market Analysis
- 15.3.1 Russia
- 15.3.19.1 Russia Market Size and Forecast, by Type
- 15.3.19.2 Russia Market Size and Forecast, by Product
- 15.3.19.3 Russia Market Size and Forecast, by Application
- 15.3.19.4 Russia Market Size and Forecast, by Technology
- 15.3.19.5 Russia Market Size and Forecast, by End User
- 15.3.19.6 Russia Market Size and Forecast, by Process
- 15.3.19.7 Russia Market Size and Forecast, by Mode
- 15.3.19.8 Russia Market Size and Forecast, by Stage
- 15.3.19.9 Local Competition Analysis
- 15.3.19.10 Local Market Analysis
- 15.3.1 Rest of Europe
- 15.3.20.1 Rest of Europe Market Size and Forecast, by Type
- 15.3.20.2 Rest of Europe Market Size and Forecast, by Product
- 15.3.20.3 Rest of Europe Market Size and Forecast, by Application
- 15.3.20.4 Rest of Europe Market Size and Forecast, by Technology
- 15.3.20.5 Rest of Europe Market Size and Forecast, by End User
- 15.3.20.6 Rest of Europe Market Size and Forecast, by Process
- 15.3.20.7 Rest of Europe Market Size and Forecast, by Mode
- 15.3.20.8 Rest of Europe Market Size and Forecast, by Stage
- 15.3.20.9 Local Competition Analysis
- 15.3.20.10 Local Market Analysis
- 15.1 Asia-Pacific
- 15.4.1 Key Market Trends and Opportunities
- 15.4.2 Asia-Pacific Market Size and Forecast, by Type
- 15.4.3 Asia-Pacific Market Size and Forecast, by Product
- 15.4.4 Asia-Pacific Market Size and Forecast, by Application
- 15.4.5 Asia-Pacific Market Size and Forecast, by Technology
- 15.4.6 Asia-Pacific Market Size and Forecast, by End User
- 15.4.7 Asia-Pacific Market Size and Forecast, by Process
- 15.4.8 Asia-Pacific Market Size and Forecast, by Mode
- 15.4.9 Asia-Pacific Market Size and Forecast, by Stage
- 15.4.10 Asia-Pacific Market Size and Forecast, by Country
- 15.4.11 China
- 15.4.9.1 China Market Size and Forecast, by Type
- 15.4.9.2 China Market Size and Forecast, by Product
- 15.4.9.3 China Market Size and Forecast, by Application
- 15.4.9.4 China Market Size and Forecast, by Technology
- 15.4.9.5 China Market Size and Forecast, by End User
- 15.4.9.6 China Market Size and Forecast, by Process
- 15.4.9.7 China Market Size and Forecast, by Mode
- 15.4.9.8 China Market Size and Forecast, by Stage
- 15.4.9.9 Local Competition Analysis
- 15.4.9.10 Local Market Analysis
- 15.4.1 India
- 15.4.10.1 India Market Size and Forecast, by Type
- 15.4.10.2 India Market Size and Forecast, by Product
- 15.4.10.3 India Market Size and Forecast, by Application
- 15.4.10.4 India Market Size and Forecast, by Technology
- 15.4.10.5 India Market Size and Forecast, by End User
- 15.4.10.6 India Market Size and Forecast, by Process
- 15.4.10.7 India Market Size and Forecast, by Mode
- 15.4.10.8 India Market Size and Forecast, by Stage
- 15.4.10.9 Local Competition Analysis
- 15.4.10.10 Local Market Analysis
- 15.4.1 Japan
- 15.4.11.1 Japan Market Size and Forecast, by Type
- 15.4.11.2 Japan Market Size and Forecast, by Product
- 15.4.11.3 Japan Market Size and Forecast, by Application
- 15.4.11.4 Japan Market Size and Forecast, by Technology
- 15.4.11.5 Japan Market Size and Forecast, by End User
- 15.4.11.6 Japan Market Size and Forecast, by Process
- 15.4.11.7 Japan Market Size and Forecast, by Mode
- 15.4.11.8 Japan Market Size and Forecast, by Stage
- 15.4.11.9 Local Competition Analysis
- 15.4.11.10 Local Market Analysis
- 15.4.1 South Korea
- 15.4.12.1 South Korea Market Size and Forecast, by Type
- 15.4.12.2 South Korea Market Size and Forecast, by Product
- 15.4.12.3 South Korea Market Size and Forecast, by Application
- 15.4.12.4 South Korea Market Size and Forecast, by Technology
- 15.4.12.5 South Korea Market Size and Forecast, by End User
- 15.4.12.6 South Korea Market Size and Forecast, by Process
- 15.4.12.7 South Korea Market Size and Forecast, by Mode
- 15.4.12.8 South Korea Market Size and Forecast, by Stage
- 15.4.12.9 Local Competition Analysis
- 15.4.12.10 Local Market Analysis
- 15.4.1 Australia
- 15.4.13.1 Australia Market Size and Forecast, by Type
- 15.4.13.2 Australia Market Size and Forecast, by Product
- 15.4.13.3 Australia Market Size and Forecast, by Application
- 15.4.13.4 Australia Market Size and Forecast, by Technology
- 15.4.13.5 Australia Market Size and Forecast, by End User
- 15.4.13.6 Australia Market Size and Forecast, by Process
- 15.4.13.7 Australia Market Size and Forecast, by Mode
- 15.4.13.8 Australia Market Size and Forecast, by Stage
- 15.4.13.9 Local Competition Analysis
- 15.4.13.10 Local Market Analysis
- 15.4.1 Singapore
- 15.4.14.1 Singapore Market Size and Forecast, by Type
- 15.4.14.2 Singapore Market Size and Forecast, by Product
- 15.4.14.3 Singapore Market Size and Forecast, by Application
- 15.4.14.4 Singapore Market Size and Forecast, by Technology
- 15.4.14.5 Singapore Market Size and Forecast, by End User
- 15.4.14.6 Singapore Market Size and Forecast, by Process
- 15.4.14.7 Singapore Market Size and Forecast, by Mode
- 15.4.14.8 Singapore Market Size and Forecast, by Stage
- 15.4.14.9 Local Competition Analysis
- 15.4.14.10 Local Market Analysis
- 15.4.1 Indonesia
- 15.4.15.1 Indonesia Market Size and Forecast, by Type
- 15.4.15.2 Indonesia Market Size and Forecast, by Product
- 15.4.15.3 Indonesia Market Size and Forecast, by Application
- 15.4.15.4 Indonesia Market Size and Forecast, by Technology
- 15.4.15.5 Indonesia Market Size and Forecast, by End User
- 15.4.15.6 Indonesia Market Size and Forecast, by Process
- 15.4.15.7 Indonesia Market Size and Forecast, by Mode
- 15.4.15.8 Indonesia Market Size and Forecast, by Stage
- 15.4.15.9 Local Competition Analysis
- 15.4.15.10 Local Market Analysis
- 15.4.1 Taiwan
- 15.4.16.1 Taiwan Market Size and Forecast, by Type
- 15.4.16.2 Taiwan Market Size and Forecast, by Product
- 15.4.16.3 Taiwan Market Size and Forecast, by Application
- 15.4.16.4 Taiwan Market Size and Forecast, by Technology
- 15.4.16.5 Taiwan Market Size and Forecast, by End User
- 15.4.16.6 Taiwan Market Size and Forecast, by Process
- 15.4.16.7 Taiwan Market Size and Forecast, by Mode
- 15.4.16.8 Taiwan Market Size and Forecast, by Stage
- 15.4.16.9 Local Competition Analysis
- 15.4.16.10 Local Market Analysis
- 15.4.1 Malaysia
- 15.4.17.1 Malaysia Market Size and Forecast, by Type
- 15.4.17.2 Malaysia Market Size and Forecast, by Product
- 15.4.17.3 Malaysia Market Size and Forecast, by Application
- 15.4.17.4 Malaysia Market Size and Forecast, by Technology
- 15.4.17.5 Malaysia Market Size and Forecast, by End User
- 15.4.17.6 Malaysia Market Size and Forecast, by Process
- 15.4.17.7 Malaysia Market Size and Forecast, by Mode
- 15.4.17.8 Malaysia Market Size and Forecast, by Stage
- 15.4.17.9 Local Competition Analysis
- 15.4.17.10 Local Market Analysis
- 15.4.1 Rest of Asia-Pacific
- 15.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
- 15.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
- 15.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Application
- 15.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
- 15.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by End User
- 15.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Process
- 15.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Mode
- 15.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Stage
- 15.4.18.9 Local Competition Analysis
- 15.4.18.10 Local Market Analysis
- 15.1 Latin America
- 15.5.1 Key Market Trends and Opportunities
- 15.5.2 Latin America Market Size and Forecast, by Type
- 15.5.3 Latin America Market Size and Forecast, by Product
- 15.5.4 Latin America Market Size and Forecast, by Application
- 15.5.5 Latin America Market Size and Forecast, by Technology
- 15.5.6 Latin America Market Size and Forecast, by End User
- 15.5.7 Latin America Market Size and Forecast, by Process
- 15.5.8 Latin America Market Size and Forecast, by Mode
- 15.5.9 Latin America Market Size and Forecast, by Stage
- 15.5.10 Latin America Market Size and Forecast, by Country
- 15.5.11 Brazil
- 15.5.9.1 Brazil Market Size and Forecast, by Type
- 15.5.9.2 Brazil Market Size and Forecast, by Product
- 15.5.9.3 Brazil Market Size and Forecast, by Application
- 15.5.9.4 Brazil Market Size and Forecast, by Technology
- 15.5.9.5 Brazil Market Size and Forecast, by End User
- 15.5.9.6 Brazil Market Size and Forecast, by Process
- 15.5.9.7 Brazil Market Size and Forecast, by Mode
- 15.5.9.8 Brazil Market Size and Forecast, by Stage
- 15.5.9.9 Local Competition Analysis
- 15.5.9.10 Local Market Analysis
- 15.5.1 Mexico
- 15.5.10.1 Mexico Market Size and Forecast, by Type
- 15.5.10.2 Mexico Market Size and Forecast, by Product
- 15.5.10.3 Mexico Market Size and Forecast, by Application
- 15.5.10.4 Mexico Market Size and Forecast, by Technology
- 15.5.10.5 Mexico Market Size and Forecast, by End User
- 15.5.10.6 Mexico Market Size and Forecast, by Process
- 15.5.10.7 Mexico Market Size and Forecast, by Mode
- 15.5.10.8 Mexico Market Size and Forecast, by Stage
- 15.5.10.9 Local Competition Analysis
- 15.5.10.10 Local Market Analysis
- 15.5.1 Argentina
- 15.5.11.1 Argentina Market Size and Forecast, by Type
- 15.5.11.2 Argentina Market Size and Forecast, by Product
- 15.5.11.3 Argentina Market Size and Forecast, by Application
- 15.5.11.4 Argentina Market Size and Forecast, by Technology
- 15.5.11.5 Argentina Market Size and Forecast, by End User
- 15.5.11.6 Argentina Market Size and Forecast, by Process
- 15.5.11.7 Argentina Market Size and Forecast, by Mode
- 15.5.11.8 Argentina Market Size and Forecast, by Stage
- 15.5.11.9 Local Competition Analysis
- 15.5.11.10 Local Market Analysis
- 15.5.1 Rest of Latin America
- 15.5.12.1 Rest of Latin America Market Size and Forecast, by Type
- 15.5.12.2 Rest of Latin America Market Size and Forecast, by Product
- 15.5.12.3 Rest of Latin America Market Size and Forecast, by Application
- 15.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
- 15.5.12.5 Rest of Latin America Market Size and Forecast, by End User
- 15.5.12.6 Rest of Latin America Market Size and Forecast, by Process
- 15.5.12.7 Rest of Latin America Market Size and Forecast, by Mode
- 15.5.12.8 Rest of Latin America Market Size and Forecast, by Stage
- 15.5.12.9 Local Competition Analysis
- 15.5.12.10 Local Market Analysis
- 15.1 Middle East and Africa
- 15.6.1 Key Market Trends and Opportunities
- 15.6.2 Middle East and Africa Market Size and Forecast, by Type
- 15.6.3 Middle East and Africa Market Size and Forecast, by Product
- 15.6.4 Middle East and Africa Market Size and Forecast, by Application
- 15.6.5 Middle East and Africa Market Size and Forecast, by Technology
- 15.6.6 Middle East and Africa Market Size and Forecast, by End User
- 15.6.7 Middle East and Africa Market Size and Forecast, by Process
- 15.6.8 Middle East and Africa Market Size and Forecast, by Mode
- 15.6.9 Middle East and Africa Market Size and Forecast, by Stage
- 15.6.10 Middle East and Africa Market Size and Forecast, by Country
- 15.6.11 Saudi Arabia
- 15.6.9.1 Saudi Arabia Market Size and Forecast, by Type
- 15.6.9.2 Saudi Arabia Market Size and Forecast, by Product
- 15.6.9.3 Saudi Arabia Market Size and Forecast, by Application
- 15.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
- 15.6.9.5 Saudi Arabia Market Size and Forecast, by End User
- 15.6.9.6 Saudi Arabia Market Size and Forecast, by Process
- 15.6.9.7 Saudi Arabia Market Size and Forecast, by Mode
- 15.6.9.8 Saudi Arabia Market Size and Forecast, by Stage
- 15.6.9.9 Local Competition Analysis
- 15.6.9.10 Local Market Analysis
- 15.6.1 UAE
- 15.6.10.1 UAE Market Size and Forecast, by Type
- 15.6.10.2 UAE Market Size and Forecast, by Product
- 15.6.10.3 UAE Market Size and Forecast, by Application
- 15.6.10.4 UAE Market Size and Forecast, by Technology
- 15.6.10.5 UAE Market Size and Forecast, by End User
- 15.6.10.6 UAE Market Size and Forecast, by Process
- 15.6.10.7 UAE Market Size and Forecast, by Mode
- 15.6.10.8 UAE Market Size and Forecast, by Stage
- 15.6.10.9 Local Competition Analysis
- 15.6.10.10 Local Market Analysis
- 15.6.1 South Africa
- 15.6.11.1 South Africa Market Size and Forecast, by Type
- 15.6.11.2 South Africa Market Size and Forecast, by Product
- 15.6.11.3 South Africa Market Size and Forecast, by Application
- 15.6.11.4 South Africa Market Size and Forecast, by Technology
- 15.6.11.5 South Africa Market Size and Forecast, by End User
- 15.6.11.6 South Africa Market Size and Forecast, by Process
- 15.6.11.7 South Africa Market Size and Forecast, by Mode
- 15.6.11.8 South Africa Market Size and Forecast, by Stage
- 15.6.11.9 Local Competition Analysis
- 15.6.11.10 Local Market Analysis
- 15.6.1 Rest of MEA
- 15.6.12.1 Rest of MEA Market Size and Forecast, by Type
- 15.6.12.2 Rest of MEA Market Size and Forecast, by Product
- 15.6.12.3 Rest of MEA Market Size and Forecast, by Application
- 15.6.12.4 Rest of MEA Market Size and Forecast, by Technology
- 15.6.12.5 Rest of MEA Market Size and Forecast, by End User
- 15.6.12.6 Rest of MEA Market Size and Forecast, by Process
- 15.6.12.7 Rest of MEA Market Size and Forecast, by Mode
- 15.6.12.8 Rest of MEA Market Size and Forecast, by Stage
- 15.6.12.9 Local Competition Analysis
- 15.6.12.10 Local Market Analysis
16: Competitive Landscape
- 16.1 Overview
- 16.2 Market Share Analysis
- 16.3 Key Player Positioning
- 16.4 Competitive Leadership Mapping
- 16.4.1 Star Players
- 16.4.2 Innovators
- 16.4.3 Emerging Players
- 16.5 Vendor Benchmarking
- 16.6 Developmental Strategy Benchmarking
- 16.6.1 New Product Developments
- 16.6.2 Product Launches
- 16.6.3 Business Expansions
- 16.6.4 Partnerships, Joint Ventures, and Collaborations
- 16.6.5 Mergers and Acquisitions
17: Company Profiles
- 17.1 Incyte
- 17.1.1 Company Overview
- 17.1.2 Company Snapshot
- 17.1.3 Business Segments
- 17.1.4 Business Performance
- 17.1.5 Product Offerings
- 17.1.6 Key Developmental Strategies
- 17.1.7 SWOT Analysis
- 17.2 BeiGene
- 17.2.1 Company Overview
- 17.2.2 Company Snapshot
- 17.2.3 Business Segments
- 17.2.4 Business Performance
- 17.2.5 Product Offerings
- 17.2.6 Key Developmental Strategies
- 17.2.7 SWOT Analysis
- 17.3 MacroGenics
- 17.3.1 Company Overview
- 17.3.2 Company Snapshot
- 17.3.3 Business Segments
- 17.3.4 Business Performance
- 17.3.5 Product Offerings
- 17.3.6 Key Developmental Strategies
- 17.3.7 SWOT Analysis
- 17.4 Adaptimmune Therapeutics
- 17.4.1 Company Overview
- 17.4.2 Company Snapshot
- 17.4.3 Business Segments
- 17.4.4 Business Performance
- 17.4.5 Product Offerings
- 17.4.6 Key Developmental Strategies
- 17.4.7 SWOT Analysis
- 17.5 Immunomedics
- 17.5.1 Company Overview
- 17.5.2 Company Snapshot
- 17.5.3 Business Segments
- 17.5.4 Business Performance
- 17.5.5 Product Offerings
- 17.5.6 Key Developmental Strategies
- 17.5.7 SWOT Analysis
- 17.6 Kite Pharma
- 17.6.1 Company Overview
- 17.6.2 Company Snapshot
- 17.6.3 Business Segments
- 17.6.4 Business Performance
- 17.6.5 Product Offerings
- 17.6.6 Key Developmental Strategies
- 17.6.7 SWOT Analysis
- 17.7 Juno Therapeutics
- 17.7.1 Company Overview
- 17.7.2 Company Snapshot
- 17.7.3 Business Segments
- 17.7.4 Business Performance
- 17.7.5 Product Offerings
- 17.7.6 Key Developmental Strategies
- 17.7.7 SWOT Analysis
- 17.8 Immunocore
- 17.8.1 Company Overview
- 17.8.2 Company Snapshot
- 17.8.3 Business Segments
- 17.8.4 Business Performance
- 17.8.5 Product Offerings
- 17.8.6 Key Developmental Strategies
- 17.8.7 SWOT Analysis
- 17.9 Bluebird Bio
- 17.9.1 Company Overview
- 17.9.2 Company Snapshot
- 17.9.3 Business Segments
- 17.9.4 Business Performance
- 17.9.5 Product Offerings
- 17.9.6 Key Developmental Strategies
- 17.9.7 SWOT Analysis
- 17.10 Celldex Therapeutics
- 17.10.1 Company Overview
- 17.10.2 Company Snapshot
- 17.10.3 Business Segments
- 17.10.4 Business Performance
- 17.10.5 Product Offerings
- 17.10.6 Key Developmental Strategies
- 17.10.7 SWOT Analysis
- 17.11 OncoMed Pharmaceuticals
- 17.11.1 Company Overview
- 17.11.2 Company Snapshot
- 17.11.3 Business Segments
- 17.11.4 Business Performance
- 17.11.5 Product Offerings
- 17.11.6 Key Developmental Strategies
- 17.11.7 SWOT Analysis
- 17.12 Argenx
- 17.12.1 Company Overview
- 17.12.2 Company Snapshot
- 17.12.3 Business Segments
- 17.12.4 Business Performance
- 17.12.5 Product Offerings
- 17.12.6 Key Developmental Strategies
- 17.12.7 SWOT Analysis
- 17.13 Cellectis
- 17.13.1 Company Overview
- 17.13.2 Company Snapshot
- 17.13.3 Business Segments
- 17.13.4 Business Performance
- 17.13.5 Product Offerings
- 17.13.6 Key Developmental Strategies
- 17.13.7 SWOT Analysis
- 17.14 Fate Therapeutics
- 17.14.1 Company Overview
- 17.14.2 Company Snapshot
- 17.14.3 Business Segments
- 17.14.4 Business Performance
- 17.14.5 Product Offerings
- 17.14.6 Key Developmental Strategies
- 17.14.7 SWOT Analysis
- 17.15 Gritstone Oncology
- 17.15.1 Company Overview
- 17.15.2 Company Snapshot
- 17.15.3 Business Segments
- 17.15.4 Business Performance
- 17.15.5 Product Offerings
- 17.15.6 Key Developmental Strategies
- 17.15.7 SWOT Analysis
- 17.16 Adaptimmune
- 17.16.1 Company Overview
- 17.16.2 Company Snapshot
- 17.16.3 Business Segments
- 17.16.4 Business Performance
- 17.16.5 Product Offerings
- 17.16.6 Key Developmental Strategies
- 17.16.7 SWOT Analysis
- 17.17 Allogene Therapeutics
- 17.17.1 Company Overview
- 17.17.2 Company Snapshot
- 17.17.3 Business Segments
- 17.17.4 Business Performance
- 17.17.5 Product Offerings
- 17.17.6 Key Developmental Strategies
- 17.17.7 SWOT Analysis
- 17.18 Iovance Biotherapeutics
- 17.18.1 Company Overview
- 17.18.2 Company Snapshot
- 17.18.3 Business Segments
- 17.18.4 Business Performance
- 17.18.5 Product Offerings
- 17.18.6 Key Developmental Strategies
- 17.18.7 SWOT Analysis
- 17.19 Zymeworks
- 17.19.1 Company Overview
- 17.19.2 Company Snapshot
- 17.19.3 Business Segments
- 17.19.4 Business Performance
- 17.19.5 Product Offerings
- 17.19.6 Key Developmental Strategies
- 17.19.7 SWOT Analysis
- 17.20 Compugen
- 17.20.1 Company Overview
- 17.20.2 Company Snapshot
- 17.20.3 Business Segments
- 17.20.4 Business Performance
- 17.20.5 Product Offerings
- 17.20.6 Key Developmental Strategies
- 17.20.7 SWOT Analysis
お電話でのお問い合わせ
044-952-0102
( 土日・祝日を除く )
